Evidence map›Paper›PMID 39730916›Full record

ArticleEuropean journal of human genetics : EJHG2025

Vascular Ehlers-Danlos syndrome in children: evaluating the importance of diagnosis and follow-up during childhood.

Niamh R Wilkinson, Elena Cervi, Bart Wagner, Deborah Morris-Rosendahl, Duncan Baker, Harpaul Flora, Kate von Klemperer, Toby Andrew, Neeti Ghali, Fleur S van Dijk

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Spring in EJHG.European journal of human genetics : EJHG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Niamh R WilkinsonNational EDS Service, London North West University Healthcare NHS Trust, London, UK.ORCID 0009-0004-1056-2098
Elena CerviCentre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital, London, UK.ORCID 0000-0003-2612-1014
Bart WagnerElectron Microscopy Section, Histopathology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0003-1244-3063
Deborah Morris-RosendahlClinical Genetics and Genomics Laboratory, Royal Brompton Hospital, London, UK.ORCID 0000-0002-7780-4707
Duncan BakerSheffield Diagnostic Genetics Service, Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UK.
Harpaul FloraDepartment of Vascular Surgery, Barts Heart Centre, London, UK.
Kate von KlempererAdult Congenital Heart Disease, Barts Heart Centre, London, UK.
Toby AndrewDepartment of Metabolism, Digestion and Reproduction, Section of Genetics and Genomics, Imperial College London, London, UK.
Neeti GhaliNational EDS Service, London North West University Healthcare NHS Trust, London, UK.ORCID 0000-0003-2847-1376
Fleur S van DijkNational EDS Service, London North West University Healthcare NHS Trust, London, UK. fleur.dijk@nhs.net.ORCID 0000-0001-6341-169X

Funding

Imperial College London P89680-1
6 · The paper itself

Abstract

Vascular Ehlers-Danlos syndrome (vEDS) is a rare inherited connective tissue disorder predominantly caused by pathogenic COL3A1 variants. Characteristic arterial and intestinal fragility and generalised severe tissue friability can lead to clinical events from childhood. We highlight a paucity of literature regarding children diagnosed with vEDS, possibly explained by a restraint in predictive testing, and present data on 63 individuals (23 index cases) with a clinical and genetic diagnosis of vEDS in childhood (<18 years) to address this. Patients were identified through the National Ehlers-Danlos Syndrome (EDS) Service London. We report on 18 events in childhood, recorded in 13 individuals. First events occurred at a median age of 11 years (IQR 0-13) and genetic testing was initiated as a direct result of the first event in 11/13 cases. In the cohort majority, diagnosis was the result of familial genetic testing (55%). Our findings emphasise the importance of offering genetic testing in childhood when there is a positive family history of vEDS and/or features suggestive of a potential inherited connective tissue disorder. Diagnosis in childhood allows for follow-up surveillance and informed multi-disciplinary management, in addition to genetic counselling and patient-led management including lifestyle modification. As seen in adult cohorts, we anticipate children with vEDS will experience the same protective benefit afforded by early diagnosis and present preliminary data on follow-up in childhood. Formal evaluation of the impact that diagnosis of vEDS in childhood has on disease management is needed when sufficient data is internationally available.

Indexed as

Collagen Type IIIEhlers-Danlos SyndromeGenetic TestingAdolescentChildChild, PreschoolEhlers-Danlos Syndrome, Type IVFemaleFollow-Up StudiesGenetic CounselingHumansInfantInfant, NewbornMaleCOL3A1 protein, humanCollagen Type III

Identifiers

PMID39730916
PMCPMC11893879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.